key: cord-0819781-81kl11wd
authors: Gomez, Camilo A.; Salerno, Tomas A.
title: Commentary: Cardiac Surgery in North America: Facing an inevitable “new normal”?
date: 2020-07-13
journal: J Thorac Cardiovasc Surg
DOI: 10.1016/j.jtcvs.2020.06.110
sha: ff3ca6784b6da01ad4f0452cfc8ee441d04f9f77
doc_id: 819781
cord_uid: 81kl11wd

nan

Central Message: Covid-19 has had a paradigm shift in referrals, volumes and cardiac procedures, favoring interventional procedures for CAD, and TAVR for aortic valve diseases.

The COVID-19 pandemic profoundly affected the US health care system, leading to drastic changes in the workflow to meet the challenges of the pandemic. According to the American Hospital Association, the pandemic resulted in a total four-month financial impact of $202.6 billion in losses for America's hospitals and health systems, or an average of $50.7 billion per month (1) . In this issue of the Journal, Niv Ad et al. reports the first article of its kind, dealing with the North American cardiac surgical experience with COVID-19. They demonstrated a decrease of 45% of baseline cardiac surgery case volumes. This is independent of the institutional COVID burden and deferral of non-urgent operations, which is consistent with Taskforce and Society guidance statements (2) . It should be highlighted the importance and significance of the data presented in this article, as it should not be interpreted as a mirror of the same impact of the decrease in operations in most of other the medical specialties. In general, elective procedures during these difficult times have experienced abysmal decrease in volumes.

During the pandemic, the critical role that cardiac surgery plays in the medical field was affected, mainly due to its resource-intensive need for critical care and facilities. Furthermore, cardiac surgery is directly affected by the workflow of medical cardiovascular services, as it is the final predator of a long "food chain", which makes the specialty vulnerable. Non-invasive and invasive cardiac services also suffered marked decrease in volumes which, in turn, affected cardiac surgery referrals (3) . Moreover, as mentioned by Niv Ad et al., and data from other reports, patients are reluctant to seek medical care, leading to dramatic reduction in patients presenting to hospital with myocardial infarction (3, 4) .

Is cardiac surgery facing temporary or permanent unprecedented changes in its operations. The health care system is required to have capability to provide high quality treatments to cardiac patients, while meeting patients' expectations of short hospital stays, in order to decrease the risk of exposure. Additionally, there is an imperative necessity to satisfy the health system current needs for intelligent and strategic allocation of resources. Favoring less invasive and lower cost procedures avoids ICU stays and shorten hospitalizations. Now more than ever, the heart team should play a critical role in the comprehensive assessment of case by case, with the goal of accomplishing those demands. This can be the case of patients with advanced coronary artery disease, where procedures, such as multi-vessel or high-risk percutaneous coronary artery intervention, can safely fulfill those needs in many of cases (5) . Also, in the aortic valve area, there is shift for TAVR in all risk populations (6) . These arguments weight in favor of minimally invasive procedures with rapid recovery and lower costs.

Does this signal an inevitable "new normal" for cardiac surgery in some areas? Time will tell, and this important article by NIV et al is the first one, of many more to come, depicting the venue.

American Hospital Association™: Hospitals and Health Systems Face Unprecedented Financial Pressures Due to COVID-19

MD, and the COVID-19 North American Cardiac Surgery Survey Working Group. Cardiac Surgery in North America and COVID-19: Regional Variability in Burden and Impact

Impact of the COVID-19 pandemic on interventional cardiology practice: results of the EAPCI survey

COVID-19 -Where have all the STEMIs gone?

Reduction in ST-Segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic

Shifting Paradigms in Cardiovascular Therapeutic Strategies During the COVID-19 Era

Managing Severe Aortic Stenosis in the COVID-19 Era